Wedbush Maintains Neutral on Vera Therapeutics, Raises Price Target to $33

Benzinga · 2d ago
Wedbush analyst Laura Chico maintains Vera Therapeutics (NASDAQ:VERA) with a Neutral and raises the price target from $23 to $33.